Sponsor

Merck Serono Limited, UK

Clinical research sponsor

Published trials6

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

6 shown

Effectiveness of Cladribine Tablets in Participants With Highly-active Relapsing Multiple Sclerosis (CAMELOT-MS)NCT04997148 · collaborator · 2021-08-11

COMPLETED

ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple SclerosisNCT04695080 · collaborator · 2021-06-25

ACTIVE_NOT_RECRUITING

An Observational, Retrospective, UK & Ireland Audit of Patient Adherence to Rebif® Injections Using the RebiSmart™ Injection DeviceNCT01601080 · collaborator · 2012-04-01

COMPLETED

Impact of Disease Modifying Therapies (DMTs) and Associated Support Services in Relapsing Multiple Sclerosis (RMS) PatientsNCT01601119 · collaborator · 2012-01-01

COMPLETED

Assessment of Patient Use of a New Device: RebiSmartNCT01195870 · collaborator · 2009-07-01

COMPLETED

Assessment of Subject Use of the Rebiject II Injection Device According to Nurse Examination of Subject Accuracy in 10 Steps as a Dummy DemonstrationNCT01195857 · collaborator · 2009-01-01

COMPLETED

Sponsor roles

collaborator6

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.